AbTis is a leading ADC Biotech Company with the world’s best linker platform technology4. They have developed the 3rd generation of ADC linker technology, AbClick®, which utilizes a cyclic peptide that site-selectively conjugates drugs to natural antibodies without antibody modification. It also controls the number of payloads conjugated to the linker for high yield of conjugation and simple process of purification. Therefore, AbClick® leads cost-effective ADC production with a high therapeutic index.